Retinal detachment with macular hole following intravitreal bevacizumab in patient with severe proliferative diabetic retinopathy

British Journal of Ophthalmology

Volumn 92, Issue 5, 2008, Pages 717-718

  Mitamura, Yoshinori ^a   Ogata, Kazuha ^a   Oshitari, Toshiyuki ^a   Asaumi, Noriko ^a   Yamamoto, Shuichi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; INSULIN;

ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; LETTER; NEOVASCULAR GLAUCOMA; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA HOLE; VITRECTOMY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; DIABETIC RETINOPATHY; FUNDUS OCULI; HUMANS; MALE; RETINAL DETACHMENT; RETINAL PERFORATIONS;

EID: 43649097033     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2008.139378     Document Type: Letter

References (6)

1. Arevalo JF, Maia M, Flynn H Jr, et al. Tractional retinal detachment following Intravitreal bevacizumab (Avastin®) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol 2008;92:213-16.
2. Jorge R, Costa RA, Calucci D, et al. Intravitreal bevacizumab (Avastin) for persistent new vessels in diabetic retinopathy (IBEPE study). Retina 2006;26:1006-13.
3. Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695-705.
4. Chen E, Park CH. Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina 2006;26:699-700.
5. Oshima Y, Sakaguchi H, Gomi F, et al. Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. Am J Ophthalmol 2006;142:155- 8.
6. Iliev ME, Domig D, Woff-Schnurrbursch U, et al. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol 2006;142:1054-6.